Collaboration overview
Successful development of persistent prostate cancer treatment for 1 month, ‘Luphere depot’ with the introduction of smart depot (spray drying method SR-DDS) technology from Peptron in 2005
Benefits to Daewoong Pharma
- Adoption of sustained release platform technology and successful development of products
- Promotion of the product capable of generating more than 10 billion won of annual sales
Benefits to the partner
- Achieved first commercialization of a pharmaceutical product using the based technology it has
- Royalty revenue from domestic sales
- IPO success in 2016